Health news
Among patients in South Africa who contracted SARS-CoV-2 infection during the wave dominated by the Omicron (B.1.1529) variant, fewer required hospitalization, supplemental oxygen, or transfer to an intensive care unit (ICU) compared with previous waves,…
Influenza vaccination reduces the risk of serious illness in children even when the circulating virus is antigenically different from the vaccine virus, according to a Centers for Disease Control and Prevention (CDC) study published in…
The Food and Drug Administration (FDA) has updated the Emergency Use Authorization (EUA) for the Moderna COVID-19 vaccine to allow for the administration of a single booster dose in individuals 18 years of age and…
The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) recommends the use of a single booster dose of the Pfizer-BioNTech COVID-19 vaccine in individuals 12 to 15 years of age…
The Food and Drug Administration (FDA) has granted Fast Track designation to BPZE1 for active booster immunization against pertussis. BPZE1 is an investigational live-attenuated intranasal vaccine designed to induce comprehensive and durable protection against Bordetella…
The Centers for Disease Control and Prevention (CDC) has issued updated isolation and quarantine guidance for individuals infected with and exposed to COVID-19. Individuals who have tested positive for COVID-19, regardless of vaccination status, are…
Pfizer and BioNTech have submitted a supplemental Biologics License Application to the Food and Drug Administration (FDA) for Comirnaty (COVID-19 vaccine, mRNA) to include individuals 12 to 15 years of age for active immunization to…
The Janssen COVID-19 vaccine should not be administered to individuals with a history of thrombosis with thrombocytopenia (TTS) following receipt of this vaccine or any other adenovirus-vectored COVID-19 vaccines (eg, AstraZeneca’s COVID-19 vaccine), according to…
The Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine to allow for the administration of a single booster dose to individuals 16 and 17 of age…
Early data suggest a greater increase in CD8+ T-cell response when the Janssen COVID-19 vaccine (Ad26.COV2.S), a viral vector vaccine, is administered as a booster 6 months after a 2-dose primary series with the Pfizer-BioNTech…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021